Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Pharmaceuticals Become Suit Filers Rather Than Those Being Sued (India)

This article was originally published in PharmAsia News

Executive Summary

Now that Indian generic pharmaceutical companies are developing and marketing their own drugs, their patent role is beginning to switch from being sued to filing the suits. About 40 percent of the 8,000 drug patents filed in India between 1995 and 2004 were by Indian drug makers. A university professor says many of those patent applications are considered frivolous, claiming new laboratory techniques even though they do not qualify for patents. But he noted the pipeline of discovery drugs is drying up while companies seek another patent for a drug after changing its makeup a bit. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065890

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel